Adaptive Randomization 5.2

Adaptive Randomization is a specialized software application for designing, simulating, and implementing response‑adaptive randomization in clinical trials. Developed by biostatisticians at The University of Texas MD Anderson Cancer Center, it helps investigators allocate participants to treatment arms based on accumulating outcome data, with the goals of improving trial efficiency, ethical balance, and decision-making.

Key capabilities:

• Supports multi-arm clinical trial designs with interim updates to allocation probabilities as evidence accrues.
• Offers flexible specification of endpoints and operating scenarios to evaluate performance before launch.
• Provides simulation tools to assess operating characteristics such as power, type I error, sample size, and expected allocation.
• Generates real-time or preplanned randomization assignments with options for stratification and covariate considerations.
• Produces clear reports and exportable outputs to facilitate collaboration among statisticians, clinicians, and trial operations teams.

Adaptive Randomization is intended for biostatisticians, clinical researchers, and trial managers seeking a rigorous, transparent framework for response-adaptive trial design and conduct across therapeutic areas, including but not limited to oncology. It combines methodological rigor with practical tools to support better-informed, data-driven allocation decisions throughout the life of a study.

Adaptive Randomization is developed by M. D. Anderson Cancer Center. The most popular versions of this product among our users are: 4.1 and 5.2. The name of the program executable file is ARandDesktop.exe.